Infectious Complications in Aggressive B Cell Non-Hodgkin Lymphoma after CD-19 Chimeric Antigen Receptor T Cell Therapy

Study investigated the incidence of infections following treatment with CAR T therapy for diffuse large b-cell lymphoma.